Nasdaq:EVAXPublished
Evaxion to announce strategy and business update and third quarter 2026 financial results on November 19, 2026
COPENHAGEN, Denmark, November 18, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, will provide a strategy and business update and report its third quarter 2026 financial…